COVID Protection After Transplant-Immunosuppression Reduction

NCT05077254 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

NIH

Sponsor class

Conditions

Kidney Transplant Recipients
Liver Transplant Recipients

Interventions

BIOLOGICAL: Pfizer-BioNTech COVID-19 Vaccine 2023-2024
BIOLOGICAL: Moderna COVID-19 Vaccine 2023-2024
DRUG: SOC IS Regimen
DRUG: SOC IS Reduction

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]